These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17631010)

  • 1. Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.
    Pahl E
    Pediatr Transplant; 2007 Aug; 11(5):459-60. PubMed ID: 17631010
    [No Abstract]   [Full Text] [Related]  

  • 2. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
    Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
    Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes.
    Wild S; Byrne CD
    Diabet Med; 2004 Sep; 21 Suppl 4():8-11. PubMed ID: 15315518
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
    Watts GF
    Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins. Cholesterol lowering and beyond.
    Mayo Clin Womens Healthsource; 2006 Jun; 10(6):1-2. PubMed ID: 16675916
    [No Abstract]   [Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?
    Valantine HA; Schroeder JS
    Circulation; 1997 Sep; 96(5):1370-3. PubMed ID: 9315517
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular disease, hypertension, and prevention.
    Lavie CJ
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):19A-22A. PubMed ID: 15261686
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins and cardiac allograft vasculopathy after heart transplantation.
    Kobashigawa JA
    Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). HMG-CoA reductase inhibitors: a review of published clinical trials and pharmacoeconomic evaluations.
    Int J Technol Assess Health Care; 1998; 14(2):396-8. PubMed ID: 9678976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol levels and risk of death in chronic heart failure patients referred for heart transplant evaluation.
    Lizak MK; Zakliczynski M; Jarosz A; Zembala M
    J Heart Lung Transplant; 2010 Mar; 29(3):386-7. PubMed ID: 19864166
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins, cholesterol, and the prevention of coronary heart disease.
    Freeman MW
    FASEB J; 2006 Feb; 20(2):200-1. PubMed ID: 16449790
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients.
    Vrtovec B; Stojanovic I; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Radovancevic B
    J Heart Lung Transplant; 2006 Feb; 25(2):234-6. PubMed ID: 16446226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and coronary events. The current thinking.
    Jones PH
    Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential immunosuppressive effects of statins.
    Kobashigawa JA
    Pediatr Transplant; 2008 Jun; 12(4):381-4. PubMed ID: 18331542
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies to promote HDL-C: an emerging therapeutic target.
    Nicholls SJ; Nissen SE
    Eur Heart J; 2005 May; 26(9):853-5. PubMed ID: 15764616
    [No Abstract]   [Full Text] [Related]  

  • 20. Should all patients receive statins before cardiac surgery: are more data necessary?
    Lazar HL
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):520-2. PubMed ID: 16515899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.